Metabolic / GLP-1
Cagrisema (Cagrilintide + Semaglutide)
Cagrisema combines cagrilintide (amylin analog) and semaglutide (GLP-1 agonist) for cellular studies of metabolic signaling pathways.
$174.6810 vials / kit
Dosage per vial
Size
50mg 5mg
Quality Assurance
HPLC Purity
>99%
Third-Party
Tested
Lab
Certified
For laboratory research use only. Not for human or animal consumption.